| Date Filed | Type | Description |
| 05/12/2023 |
4
| Kalb Michael Wayne (CFO) has filed a Form 4 on IMPEL PHARMACEUTICALS INC|
Txns:
| Granted 175,000 options to buy
@ $2.43, valued at
$425.3k
Granted 47,500 options to buy
@ $0 |
|
| 05/12/2023 |
3
| Kalb Michael Wayne (CFO) has filed a Form 3 on IMPEL PHARMACEUTICALS INC |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/10/2023 |
3
| Amin Rajiv (VP, Controller & Interim CFO) has filed a Form 3 on IMPEL PHARMACEUTICALS INC |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| SHAH MAHENDRA (Director) has filed a Form 4 on IMPEL PHARMACEUTICALS INC|
Txns:
| Granted 12,789 options to buy
@ $8.65, valued at
$110.6k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2022 |
4
| SHREWSBURY STEPHEN B (Chief Medical Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Exercised 24,606 options to buy
@ $1.97, valued at
$48.5k
|
|
| 01/28/2022 |
4
| SHREWSBURY STEPHEN B (Chief Medical Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 30,000 options to buy
@ $9.85, valued at
$295.5k
|
|
| 01/28/2022 |
4
| Paolillo Leonard (Chief Commercial Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 40,000 options to buy
@ $9.85, valued at
$394k
|
|
| 01/28/2022 |
4
| Leaman John Harold (Chief Fin. & Business Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 100,000 options to buy
@ $9.85, valued at
$985k
|
|
| 01/28/2022 |
4
| Hoekman John (Chief Scientific Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 35,000 options to buy
@ $9.85, valued at
$344.8k
|
|
| 01/28/2022 |
4
| ADAMS ADRIAN (COB, CEO and President) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 175,000 options to buy
@ $9.85, valued at
$1.7M
|
|
| 12/23/2021 |
4
| Hoekman John (Chief Scientific Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Exercised 20,000 options to buy
@ $1.64, valued at
$32.8k
|
|
| 11/22/2021 |
4
| NELSON TIMOTHY S (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Bought 10,000 shares
@ $10.7554, valued at
$107.6k
|
|
| 10/21/2021 |
4
| Leaman John Harold (Chief Fin. & Business Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 10,571 options to buy
@ $0 |
|
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2021 |
4
| Wilfong Diane E. (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 11,500 options to buy
@ $9.96, valued at
$114.5k
|
|
| 07/13/2021 |
4
| SHAH MAHENDRA (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 11,500 options to buy
@ $9.96, valued at
$114.5k
|
|
| 07/13/2021 |
4
| PARKER H STEWART (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 11,500 options to buy
@ $9.96, valued at
$114.5k
|
|
| 07/13/2021 |
4
| NELSON TIMOTHY S (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 11,500 options to buy
@ $9.96, valued at
$114.5k
|
|
| 07/13/2021 |
4
| Allison David D. (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 11,500 options to buy
@ $9.96, valued at
$114.5k
|
|
| 06/22/2021 |
4/A
| PARKER H STEWART (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC |
| 06/22/2021 |
3/A
| PARKER H STEWART (Director) has filed a Form 3/A on IMPEL NEUROPHARMA INC |
| 06/07/2021 |
4/A
| Hoekman John (Chief Scientific Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Converted 4,253 shares
@ $0
Converted 69,657 preferred shares
@ $0 |
|
| 04/29/2021 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Converted 710,190 shares
@ $0
Converted 98,068 shares
@ $0
Converted 474,713 shares
@ $0
Converted 65,552 shares
@ $0
Converted 440,119 shares
@ $0
Converted 60,813 shares
@ $0
Converted 315,328 shares
@ $0
Converted 43,550 shares
@ $0
Converted 89,145 shares
@ $13.5, valued at
$1.2M
Converted 12,311 shares
@ $13.5, valued at
$166.2k
Bought 505,620 shares
@ $15, valued at
$7.6M
|
|
| 04/29/2021 |
4
| 5AM Ventures V, L.P. (10% Owner) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Converted 808,259 shares
@ $0
Converted 540,265 shares
@ $0
Converted 500,932 shares
@ $0
Converted 358,878 shares
@ $0
Converted 101,457 shares
@ $13.5, valued at
$1.4M
Bought 575,000 shares
@ $15, valued at
$8.6M
Converted 13,233,885 preferred shares
@ $0
Converted 8,845,942 preferred shares
@ $0
Converted 8,201,930 options to buy
@ $0
Converted 5,876,034 preferred shares
@ $0
Converted 1,359,799 convertible notes
@ $13.5, valued at
$18.4M
|
|
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|